Nanoparticle-mediated delivery of siRNA targeting Parp1 extends survival of mice bearing tumors derived from Brca1-deficient ovarian cancer cells.

Source:http://linkedlifedata.com/resource/pubmed/id/21187397

Proc. Natl. Acad. Sci. U.S.A. 2011 Jan 11 108 2 745-50

Download in:

View as

Triples

General Info

PMID
21187397